Menopause Supplements Under Scrutiny: Are Your Claims Backed by Science?

Menopause Supplements Under Scrutiny: Are Your Claims Backed by Science? This industry warning is crucial for any business in the dietary supplements market. We dive deep into the U.S. dietary supplements market, exploring continued growth and the increasing scrutiny on product claims.

Understand the critical difference between structure/function claims and prohibited disease claims. Learn why retailers demand compliance, how UK regulators are intensifying scrutiny, and the biggest mistakes to avoid. We cover essential labeling, mandatory FDA disclaimers, substantiating all claims, New Dietary Ingredient Notifications, and cGMP compliance. Don't mistake retailer approval for regulatory compliance.

Nutri.Markets analyzes 25+ countries - regulations, retailers, competitors, and market opportunities in minutes: https://nutri.markets

This content is for educational purposes only and does not constitute legal advice.

Chapters:
00:00 Hook
00:09 U.S. Dietary Supplements Market
00:21 Market Growth Continues
00:32 Claims Under Scrutiny
00:43 Supplements Are Foods, Not Drugs
00:52 Structure/Function vs. Disease Claims
01:03 Retailers Demand Compliance
01:12 UK Regulators Intensify Scrutiny
01:21 Avoid Medicinal Claims
01:30 Labeling Essentials
01:39 Mandatory FDA Disclaimer
01:49 Substantiate All Claims
01:59 Biggest Mistakes to Avoid
02:07 New Dietary Ingredient Notification
02:15 cGMP Compliance is Essential
02:25 Retailer Approval ≠ Compliance
02:35 Cta